Health Benefits

Supporting healthy growth in infants with allergies to cows’ milk

A food allergy is “an adverse health effect arising from a specific immune response that occurs reproducibly on exposure to a given food” 17Boyce, J. A., Assa’ad, A., Burks, A. W., Jones, S. M., Sampson, H. A., Wood, R. A., Plaut, M., Cooper, S. F., Fenton, M. J., Arshad, S. H., Bahna, S. L., Beck, L. A., Byrd-Bredbenner, C., Camargo, C. A., Eichenfield, L., Furuta, G. T., Hanifin, J. M., Jones, C., Kraft, M., … Schwaninger, J. M. (2010) Guidelines for the diagnosis and management of food allergy in the United States: Summary of the NIAID-sponsored expert panel report. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2010.10.008. CMA is one of the most frequently reported food allergies in infants and toddlers 5Annesi-Maesano, I., Fleddermann, M., Hornef, M., von Mutius, E., Pabst, O., Schaubeck, M., & Fiocchi, A. (2021). Allergic diseases in infancy: I – Epidemiology and current interpretation. In World Allergy Organization Journal. https://doi.org/10.1016/j.waojou.2021.100591. Sensitisation of the immune system towards milk protein can trigger adverse symptoms in allergic infants and toddlers upon secondary (repeated) exposure. Most children grow out of their allergy, but until then, our milk protein hydrolysates can help our customers support healthy growth in children that have a CMA.

During hydrolysis, milk proteins are broken down into smaller components via an enzymatic reaction. Small peptides or amino acids are derived from intact proteins, which eliminates those proteins regarded as harmful by the immune system of infants suffering from CMA. These ingredients can be produced as partial or extensive hydrolysates, differing in the degree of hydrolysis and therefore peptide length. Extensive hydrolysates can be used in CMA or hypo-allergenic (HA) propositions, whereas partial hydrolysates can be used in HA formulas*. It has been suggested that when added to infant formula, partial hydrolysates may work to lower the risk of sensitisation of the immune system that could lead to allergy development 151Vandenplas, Y. (2017). Prevention and management of cow’s milk allergy in non-exclusively breastfed infants. In Nutrients. https://doi.org/10.3390/nu9070731. Extensive hydrolysates, on the other hand, are produced in such a way that they do not cause adverse symptoms when consumed by a child with existing CMA, while still supporting healthy growth.

Reducing the likelihood of allergies later in life

During early life, infants can be susceptible to developing food allergies. Factors influencing this include family history, gender, ethnicity, pre-existing atopic dermatitis and genetic predisposition 29Du Toit, G., Tsakok, T., Lack, S., & Lack, G. (2016). Prevention of food allergy. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2016.02.005. Because the infant immune system is still immature and unbalanced 136Simon, A. K., Hollander, G. A., & McMichael, A. (2015). Evolution of the immune system in humans from infancy to old age. In Proceedings of the Royal Society B: Biological Sciences. https://doi.org/10.1098/rspb.2014.3085 , and the intestinal wall may be more permeable in early life, enhanced exposure to food allergens may occur during this time 52Groschwitz, K. R., & Hogan, S. P. (2009). Intestinal barrier function: Molecular regulation and disease pathogenesis. In Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2009.05.038 .

In these first years, a familiar pattern of allergy development has been recognized and is referred to as the ’allergic march’. The allergic march hypothesises how different allergies consecutively manifest over time. For example, it has been shown that atopic eczema and food allergy usually manifest during infancy, while asthma incidence peaks around the age of five and rhinitis as late as ten years of age (Barnetson, & Rogers, 2002). Because halting this pattern may benefit health later in life, CMA management in the early years is important.

Parental concerns about infant allergies

Our new consumer research (Innova and RFC, 2020) reveals why allergies are a major priority for parents

  • 54% of parents of children < 1 year old are very concerned that their infant might develop an allergy.
  • When it comes to allergy symptoms, parents are most concerned about their child suffering from respiratory issues such as those during asthma or hay fever (29%), as well as diarrhoea (24%).
  • Around 15% of parents believe hydrolysates positively impact (i.e. reduce the likelihood or severity of) allergies

Related Ingredients

Hydrolysates

related ingredient slider image

Hyvital® Whey EtD 100

  • Mildly hydrolysed whey protein

  • Designed for digestive comfort positionings 

  • May facilitate easier digestion

Download data sheet Request a Sample

Hyvital® Whey EtD 100 Organic

  • Mildly hydrolysed whey protein

  • Organic-certified

  • Neutral odour and taste

Download data sheet Request a Sample

Hyvital® Whey EtD 120

  • Mildly hydrolysed whey protein

  • Designed for digestive comfort positionings 

  • Low in bitterness

Download data sheet Request a Sample

Hyvital® Whey HA 300

  • Partially hydrolysed whey hydrolysate

  • Designed for use in HA formulas (non-EU)

  • Low in bitterness

Download data sheet Request a Sample

Hyvital® Whey CMA 500

  • Extensively hydrolysed whey hydrolysate

  • Designed for infants with CMA

  • High heat stability, low in lactose

Download data sheet Request a Sample

Hyvital® Casein HA 300

  • Partially hydrolysed casein hydrolysate

  • Designed for use in HA formulas (non-EU)

  • Low in bitterness

Download data sheet Request a Sample

Hyvital® Casein CMA 500

  • Extensively hydrolysed casein hydrolysate

  • Designed for infants with CMA

  • High heat stability, low in lactose

Download data sheet Request a Sample

Other Health Benefits

Explore Our Areas of Expertise

Explore Our Areas of Expertise

Partner with us to support healthy growth

FrieslandCampina Ingredients is proud to play a global leadership role in the development of milk protein hydrolysates, backed by over 75 years of experience in ingredient manufacturing and research in early life nutrition. Discover how our milk protein hydrolysate solutions can help our customers support healthy growth in children with CMA.

Get in touch Contact our experts

* In EU, only if it complies to the annex of delegated regulation 2016/127